LexDanaLexDanabeta
Inventor

KAREN NUGENT

Inventor
GB

Overview

2→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
Y02ATechnologies for adaptation to climate change13%
PatentTitleYear
12,186,375Factor VIII chimeric and hybrid polypeptides, and methods of use thereof202511,266,720Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to BIOVERATIV THERAPEUTICS INC (2)· patent assignee history
2022–2025Based in GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOVERATIV THERAPEUTICS INC22022–2025
Locations
LocationPatentsSpan
GB22022–2025